Title | Author(s) | Issue date | ???itemlist.??? |
BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome | Saridaki, Z.; Papadatos-Pastos, D.; Tzardi, M.; Mavroudis, D.; Bairaktari, E.; Arvanity, H.; Stathopoulos, E.; Georgoulias, V.; Souglakos, J. | 24-Nov-2015 | - |
'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer | Pallis, A. G.; Voutsina, A.; Kalikaki, A.; Souglakos, J.; Briasoulis, E.; Murray, S.; Koutsopoulos, A.; Tripaki, M.; Stathopoulos, E.; Mavroudis, D.; Georgoulias, V. | 24-Nov-2015 | - |
Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabine | Pappas, P.; Mavroudis, D.; Nikolaidou, M.; Georgoulias, V.; Marselos, M. | 24-Nov-2015 | - |
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours | Bozionelou, V.; Vamvakas, L.; Pappas, P.; Agelaki, S.; Androulakis, N.; Kalykaki, A.; Nikolaidou, M.; Kentepozidis, N.; Giassas, S.; Marselos, M.; Georgoulias, V.; Mavroudis, D. | 24-Nov-2015 | - |
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumors | Kalbakis, K.; Pappas, P.; Kouroussis, C.; Vamvakas, L.; Kalykaki, A.; Vardakis, N.; Nikolaidou, M.; Marselos, M.; Georgoulias, V.; Mavroudis, D. | 24-Nov-2015 | - |
A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors | Saridaki, Z.; Pappas, P.; Souglakos, J.; Nikolaidou, M.; Vardakis, N.; Kotsakis, A.; Marselos, M.; Georgoulias, V.; Mavroudis, D. | 24-Nov-2015 | - |
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors | Mavroudis, D.; Pappas, P.; Kouroussis, C.; Kakolyris, S.; Agelaki, S.; Kalbakis, K.; Androulakis, N.; Souglakos, J.; Vardakis, N.; Nikolaidou, M.; Samonis, G.; Marselos, M.; Georgoulias, V. | 24-Nov-2015 | - |
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Pectasides, D.; Kalogera-Fountzila, A.; Skarlos, D.; Kalofonos, H. P.; Papadimitriou, C.; Bafaloukos, D.; Lambropoulos, S.; Papadopoulos, S.; Kourea, H.; Markopoulos, C.; Linardou, H.; Mavroudis, D.; Briasoulis, E.; Pavlidis, N.; Razis, E.; Kosmidis, P.; Gogas, H. | 24-Nov-2015 | - |
PROGNOSTIC SIGNIFICANCE OF GENE EXPRESSION PROFILE IN PATIENTS WITH CARCINOMAS OF UNKNOWN PRIMARY (CAUP) | Souglakos, J.; Pentheroudakis, G.; Papadaki, C.; Cervantes, A.; Petrakis, D.; Roodriguez-Braun, E.; Lagoudaki, E.; Georgoulias, V.; Mavroudis, D.; Pavlidis, N. | 24-Nov-2015 | - |